Calcium Antagonists Interactions

Precipitation of ceftriaxone-calcium can occur when mixed with calcium-containing solutions in the same IV line. Must not be administered simultaneously but can be given sequentially.

Source: NLP:ceftriaxone sodium

May cause atrioventricular conduction disturbances, left ventricular failure, and hypotension. Should be avoided in patients with impaired cardiac function.

Source: NLP:brimonidine tartrate and timolol maleate

Caution advised; may cause atrioventricular conduction disturbances, left ventricular failure, and hypotension. Avoid in patients with impaired cardiac function.

Source: NLP:dorzolamide hydrochloride timolol maleate

Isoflurane may lead to marked hypotension in patients treated with calcium antagonists.

Source: NLP:isoflurane

Sevoflurane may lead to marked hypotension in patients treated with calcium antagonists. Blood pressure should be closely monitored.

Source: NLP:sevoflurane

Addition of sodium bicarbonate to parenteral solutions containing calcium should be avoided; precipitation or haze may result from sodium bicarbonate/calcium admixtures.

Source: NLP:sodium bicarbonate

Co-administration may cause atrioventricular conduction disturbances, left ventricular failure, and hypotension; should be avoided in patients with impaired cardiac function.

Source: NLP:timolol

May cause atrioventricular conduction disturbances, left ventricular failure, and hypotension. Should be avoided in patients with impaired cardiac function.

Source: NLP:timolol hemihydrate

Caution recommended due to possible atrioventricular conduction disturbances, left ventricular failure, and hypotension. Coadministration should be avoided in patients with impaired cardiac function.

Source: NLP:timolol maleate

Caution advised due to possible atrioventricular conduction disturbances, left ventricular failure, or hypotension. Avoid in patients with impaired cardiac function.

Source: NLP:timolol maleate ophthalmic gel forming solution

Calcium supplements interfere with absorption of alendronate sodium. Patients should wait at least one-half hour after taking alendronate sodium before taking calcium supplements.

Source: NLP:alendronate sodium

Uncontrolled intake of additional calcium-containing preparations should be avoided.

Source: NLP:calcitriol

Uncontrolled intake of additional calcium-containing preparations should be avoided during calcitriol therapy.

Source: NLP:calcitriol capsules 0.25 mcg

Concomitant administration of high doses of calcium-containing preparations may increase the risk of hypercalcemia. Monitor serum calcium concentrations more frequently.

Source: NLP:doxercalciferol

Absorption of tetracyclines is impaired by antacids containing calcium.

Source: NLP:doxycycline

Calcium-containing antacids impair absorption of tetracyclines.

Source: NLP:doxycycline hyclate

Calcium supplements interfere with absorption of ibandronate. Patients should take ibandronate at least 60 minutes before calcium supplements.

Source: NLP:ibandronate sodium

CNS depression and peripheral transmission defects from magnesium may be antagonized by calcium administration.

Source: NLP:magnesium sulfate

Calcium supplements interfere with the absorption of risedronate when co-administered.

Source: NLP:risedronate sodium

Coadministration may impair SEYSARA absorption and decrease efficacy. Separate dosing required.

Source: NLP:sarecycline hydrochloride

Sodium bicarbonate should be avoided in admixtures with calcium-containing solutions; precipitation or haze may result.

Source: NLP:sodium bicarbonate injection,

May bind phosphate and prevent its absorption.

Source: NLP:dibasic sodium phosphate, monobasic potassium phosphate and monobasic sodium phosphate

High levels of calcium from concomitant medications may alter biodistribution of technetium Tc 99m pyrophosphate, reducing skeletal uptake and increasing extraosseous uptake, potentially degrading imaging quality.

Source: NLP:technetium tc 99m pyrophosphate

Calcium may reduce absorption of CUVRIOR. If concomitant use unavoidable, separate administration by at least 1 hour before or 2 hours after.

Source: NLP:trientine tetrahydrochloride

Used concomitantly with enalapril maleate without evidence of clinically significant adverse interactions.

Source: NLP:enalapril maleate

Enalapril has been used concomitantly without evidence of clinically significant adverse interactions.

Source: NLP:enalapril maleate and hydrochlorothiazide